Literature DB >> 25712487

Nano-carrier systems: Strategies to overcome the mucus gel barrier.

S Dünnhaupt1, O Kammona2, C Waldner1, C Kiparissides3, A Bernkop-Schnürch4.   

Abstract

The present review provides an overview of nanotechnology-based strategies to overcome various mucus gel barriers including the intestinal, nasal, ocular, vaginal, buccal and pulmonary mucus layer without destroying them. It focuses on the one hand on strategies to improve the mucus permeation behavior of particles and on the other hand on systems avoiding the back-diffusion of particles out of the mucus gel layer. Nanocarriers with improved mucus permeation behavior either exhibit a high density of positive and negative charges, bearing mucolytic enzymes such as papain and bromelain on their surface or display a slippery surface due to PEG-ylation. Furthermore, self-nanoemulsifying-drug-delivery-systems (SNEDDS) turned out to exhibit comparatively high mucus permeating properties. Strategies in order to avoid back-diffusion are based on thiolated polymers reacting to a higher extent with cysteine subunits of the mucus at pH 7 in deeper mucus regions than at pH 5 being prevalent in luminal mucus regions of the intestinal and vaginal mucosa. Furthermore, particles changing their zeta potential from negative to positive once they have reached the epithelium seem to be promising carriers. The summarized knowledge should provide a good starting point for further developments in this field.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Back-diffusion; Innovative strategies; Mucus barrier; Mucus penetration; Nanocarriers; Proteolytic enzymes

Mesh:

Substances:

Year:  2015        PMID: 25712487     DOI: 10.1016/j.ejpb.2015.01.022

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  13 in total

Review 1.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

2.  Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery.

Authors:  Jasmim Leal; Xiujuan Peng; Xinquan Liu; Dhivya Arasappan; Dennis C Wylie; Sarah H Schwartz; Jason J Fullmer; Bennie C McWilliams; Hugh D C Smyth; Debadyuti Ghosh
Journal:  J Control Release       Date:  2020-03-31       Impact factor: 9.776

Review 3.  Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.

Authors:  Hannah C Zierden; Aditya Josyula; Rachel L Shapiro; Henry T Hsueh; Justin Hanes; Laura M Ensign
Journal:  Trends Mol Med       Date:  2021-01-04       Impact factor: 11.951

Review 4.  Nanotechnology-based immunotherapies to combat cancer metastasis.

Authors:  Yuping Zhao; Muhammad Bilal; Maimoona Qindeel; Muhammad Imran Khan; Kuldeep Dhama; Hafiz M N Iqbal
Journal:  Mol Biol Rep       Date:  2021-08-23       Impact factor: 2.316

Review 5.  The challenges of oral drug delivery via nanocarriers.

Authors:  Jonas Reinholz; Katharina Landfester; Volker Mailänder
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 6.  Mechanistic Approaches of Internalization, Subcellular Trafficking, and Cytotoxicity of Nanoparticles for Targeting the Small Intestine.

Authors:  Asadullah Madni; Sadia Rehman; Humaira Sultan; Muhammad Muzamil Khan; Faiz Ahmad; M Rafi Raza; Nadia Rai; Farzana Parveen
Journal:  AAPS PharmSciTech       Date:  2020-11-22       Impact factor: 3.246

7.  Dual-Acting Zeta-Potential-Changing Micelles for Optimal Mucus Diffusion and Enhanced Cellular Uptake after Oral Delivery.

Authors:  Ahmad Malkawi; Nasr Alrabadi; Ross Allan Kennedy
Journal:  Pharmaceutics       Date:  2021-06-27       Impact factor: 6.321

Review 8.  Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.

Authors:  Yara Al Ojaimi; Timothée Blin; Juliette Lamamy; Matthieu Gracia; Aubin Pitiot; Caroline Denevault-Sabourin; Nicolas Joubert; Jean-Pierre Pouget; Valérie Gouilleux-Gruart; Nathalie Heuzé-Vourc'h; Débora Lanznaster; Sophie Poty; Thomas Sécher
Journal:  Pharmacol Ther       Date:  2021-10-20       Impact factor: 13.400

9.  Development of Self-Emulsifying Drug Delivery Systems (SEDDSs) Displaying Enhanced Permeation of the Intestinal Mucus Following Sustained Release of Prototype Thiol-Based Mucolytic Agent Load.

Authors:  Ahmad Malkawi; Nasr Alrabadi; Razan Haddad; Azhar Malkawi; Khaled Khaled; Airemwen Collins Ovenseri
Journal:  Molecules       Date:  2022-07-19       Impact factor: 4.927

Review 10.  Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.

Authors:  Deepak A Subramanian; Robert Langer; Giovanni Traverso
Journal:  J Nanobiotechnology       Date:  2022-08-06       Impact factor: 9.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.